Kamada (KMDA) Shares Outstanding (2012 - 2026)

Kamada (KMDA) posted quarterly Shares Outstanding (Entity) of $15.1 million for Q1 2026, little changed year-on-year from $15.1 million in Q1 2025, and down 73.86% on a QoQ basis from $57.7 million in Q4 2025.

Kamada (KMDA) Shares Outstanding (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Shares Outstanding (Entity) for 14 consecutive years, with $15.1 million the latest figure, recorded in Q1 2026.

  • Quarterly Shares Outstanding (Entity) changed 0.03% year-over-year to $15.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.1 million (changed 0.03% YoY) and the FY2025 annual result came in at $57.7 million, changed 0.31% from the prior year.
  • Shares Outstanding (Entity) fell to $15.1 million in Q1 2026 per KMDA's latest filing, from $57.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for KMDA reached as high as $57.7 million in Q4 2025 and fell as low as $6.7 million in Q2 2024.
  • A 5-year average of $27.6 million and a median of $15.1 million in 2025 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 336.86% — and 2023, when it sank 67.58%.
  • Year by year, Shares Outstanding (Entity) stood at $44.8 million in 2022, then gained by 28.21% to $57.5 million in 2023, then climbed by 0.04% to $57.5 million in 2024, then grew by 0.31% to $57.7 million in 2025, then tumbled by 73.86% to $15.1 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $15.1 million, $57.7 million, and $15.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 8.98 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.16 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 422.10 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 43.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 455,871.00
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 100.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 497.70 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 57.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 57.65 Mn
Dec 31, 2025 57.65 Mn
Sep 30, 2025 57.49 Mn
Jun 30, 2025 57.49 Mn
Mar 31, 2025 57.49 Mn
Dec 31, 2024 57.49 Mn
Sep 30, 2024 6.67 Mn
Jun 30, 2024 6.67 Mn
Mar 31, 2024 48.83 Mn
Dec 31, 2023 48.83 Mn
Sep 30, 2023 44.82 Mn
Jun 30, 2023 44.82 Mn
Mar 31, 2023 44.82 Mn
Dec 31, 2022 44.82 Mn
Sep 30, 2022 51.20 Mn
Jun 30, 2022 36.20 Mn
Mar 31, 2022 44.77 Mn
Dec 31, 2021 44.77 Mn
Sep 30, 2021 44.14 Mn
Jun 30, 2021 44.14 Mn